The time course of neuroendocrine activation Plasma concentrations of renin, angiotensin II, and aldosterone are generally increased by the time patients suffering from myocardial infarction are admitted to the hospital." In patients with uncomplicated myocardial infarction, studies have suggested that plasma concentrations of renin, angiotensin II, and aldosterone rise only slightly before returning to normal levels during the first three days following infarction. However, in patients developing heart failure requiring diuretics, activation is exaggerated and sustained.'-3 Patients who have sustained large infarcts but who have not required diuretic therapy also have increased renin-angiotensin-aldosterone system (RAAS) activity up to two weeks after infarction,5 6 but probably not in the long term.7-'0 Plasma angiotensin converting enzyme (ACE) activity does not change,2 suggesting that activation of renin rather than ACE is responsible for the rise in angiotensin II after infarction. The possibility that tissue RAAS is activated after myocardial infarction is discussed in more detail below.
Plasma concentrations of noradrenaline and adrenaline are also raised early after infarction and decline progressively thereafter.'" Mean levels are still slightly above those of control groups at discharge in patients with uncomplicated myocardial infarction.' Regardless of diuretic treatment, patients sustaining large infarctions have raised noradrenaline levels that can remain high 14 days after infarction.5 6 In contrast to plasma renin, plasma concentrations of noradrenaline remain elevated in patients with chronic asymptomatic left ventricular dysfunction'0 or untreated heart failure.7-9 Plasma concentrations of neuropeptide Y, a substance co-secreted with noradrenaline from sympathetic nerve terminals, are also markedly raised initially. Neuropeptide Y concentrations peak approximately eight hours after myocardial infarction and return to the normal range within two to three days unless heart failure supervenes, in which case they may become chronically elevated in patients suffering from heart failure."I 12 Cardiac sympathetic activity, measured by noradrenaline spillover, is also increased in unstable angina.'3 Plasma concentrations of antidiuretic hormone (ADH) are markedly raised early after infarction but decline rapidly.' 14 ADH is raised in patients with chronic asymptomatic left ventricular dysfunction, suggesting that the hormone is chronically activated after large infarctions. 10 Plasma concentrations of endothelin are also raised in patients suffering from myocardial infarction.'5 16 The values are elevated immediately after infarction and tend to increase further in the ensuing hours, before subsiding to normal levels over the following weeks, unless complications occur. '7-'9 Patients suffering from myocardial infarction have raised plasma concentrations of atrial natriuretic factor (ANF) upon admission to the hospital. The by hypo-activation after myocardial infarction and liver) Myocardial infarction is painful, provokes c system. intense anxiety, and is often associated with of numer-tachycardia and sometimes hypoxia. It may molecules cause a fall in cardiac output and renal perfungiotensin sion which leads to activation of arterial baroreflexes. In addition, myocardial infarction causes homeosta-a rise in left ventricular diastolic pressure and S is signif-therefore atrial pressures, and is treated with a nyocardial cocktail of agents. All of these effects are likely to *amatically alter neuroendocrine function. In addition, as and ACE the heart is itself a neuroendocrine organ, local Neuroendocrine activation after myocardial infarction plasma noradrenaline.' 37 Tachycardia resulting from increased sympathetic activity could also lead to an increase in ANF.
ARTERIAL BAROREFLEX ACTIVATION
A decrease in arterial pressure leads to baroreflex activation and an increase in sympathetic activation. Head-up tilt activates arterial baroreflexes and increases plasma noradrenaline. The rise in plasma noradrenaline with head-up tilt appears to be increased late (one month) after myocardial infarction. This is associated with an exaggerated increase in angiotensin II.2 This is somewhat surprising and awaits confirmation, as arterial baroreflexes have been reported to be blunted after myocardial infarction and in heart failure.
Exercise also increases plasma ANF, renin, and noradrenaline. The increase in ANF levels during exercise appears exaggerated in patients two to three weeks after infarction. The increases in renin and noradrenaline are not significantly different from those found in healthy controls.38
Renal vasoconstriction Renal vasoconstriction is well documented after infarction and initially reflects sympathetic activation. 39 There is little post-infarction data on the use of calcium antagonists. In heart failure, calcium antagonists generally increase renin-angiotensin and sympathetic nervous system activity.42 It is unclear whether newer dihydropiridine calcium antagonists have a similar effect on these systems.
ACE INHIBITORS
ACE inhibitors inhibit the production of angiotensin II4 49 and reduce plasma concentrations of aldosterone and noradrenaline4 49 in the early hours after infarction. In patients who have sustained large infarcts, ACE inhibitors suppress the sustained increase in angiotensin II and aldosterone.50 However, in patients with uncomplicated infarcts, it is difficult to determine the continuing effect of ACE inhibitors because neuroendocrine variables decline naturally in the days following myocardial infarction.2351 The natriuretic peptides are markers of ventricular dysfunction and, as ACE inhibitors have beneficial effects on remodelling, it is not surprising that some studies245' 52 suggest that ACE inhibitors reduce levels of natriuretic peptides, though there are exceptions.50 There is no rebound increase in NT-ANF after withdrawal from six months of treatment with enalapril.52
Effects of genotype The DD polymorphism of the ACE gene is associated with higher circulating levels of ACE which could influence post-infarction remodelling. The DD genotype is associated with a greater increase in plasma noradrenaline in the early hours of infarction and a more marked degree of long term cardiac dilatation. 53 Although ACE inhibitors exert a favourable effect on ventricular remodelling, it is not certain whether this reflects solely their effect on haemodynamics or also a more direct action on the myocardium.
Vascular effects
Increases in angiotensin II, sympathetic activity, and ADH cause arterial constriction, which increases the afterload on the damaged heart. Increases in afterload may result in an increase in preload, as the damaged ventricle fails to discharge its contents adequately. This leads to ventricular dilatation. Local arteriolar constriction at the site of infarction may also be beneficial, by helping to prevent haemorrhage into the infarct. Sympathetic activation has powerful venoconstrictor effects that may be enhanced by angiotensin II and ADH. This results in an exacerbation of the rise in preload. ANF and BNP, as well as increases in vasodilator prostaglandins and nitric oxide, limit vasoconstriction but are overwhelmed when heart failure occurs. Vasoconstriction may be superseded by structural changes in vascular architecture in the systemic and pulmonary circulations that may be difficult or impossible to reverse. It is likely that neuroendocrine activation plays an important role in the transition from functional to structural increases in vascular resistance.
Renal effects
The cause of salt and water retention in human heart failure is unknown. Animal experiments suggest that the RAAS or sympathetic nervous system may be critical to the development of renal sodium and water retention. Aldosterone antagonists, ACE inhibitors, or drugs that interfere with the sympathetic nervous system do not prevent salt and water retention in heart failure. Only one study of ACE inhibitors in heart failure has noted a reduction in body weight compared to placebo.55 Although ACE inhibitors improve renal blood flow in myocardial infarction39 and in heart failure,43 46 they impair glomerular filtration.
Effects on arrhythmias The effect of angiotensin II on arrhythmias remains controversial, although most postinfarction studies have shown that ACE inhibitors reduce ventricular arrhythmias.4956
There is considerable evidence that sympathetic activation is arrhythmogenic. Activation of both the RAAS and the sympathetic nervous system is capable of producing hypokalaemia and inhibition of aldosterone formation, or the P2 receptor may be beneficial in this respect.
Neuroendocrine activation and prognosis
Data from the SAVE and CONSENSUS II studies and a series of smaller studies have related neuroendocrine variables to prognosis after infarction.' 28 57 62 These data could be used in at least three ways. First, neuroen- group.bmj.com on October 15, 2017 -Published by http://heart.bmj.com/ Downloaded from predict prognosis. Table 2 shows the sensitivity, specificity, and predictive value for mortality based on neuroendocrine variables.
Plasma concentrations of ANF-and possibly endothelin-above the median identify half of the population that has a one-year mortality rate of < 5%, even if the ejection fraction is low.62 Thus simple measurement of a neuroendocrine variable could identify a large part of the population which was at low risk and did not need further investigation. On the other hand, the mortality of patients with ANF above the median is probably about 20% at one year. This would appear to be a population at sufficiently high risk to warrant aggressive management.
Currently only NT-ANF has been suggested to carry prognostic information over and above ventricular ejection fraction. However, it is possible that some neuroendocrine variables may be simpler and less expensive to measure than ejection fraction, in which case the onus would be on the latter to prove predictive superiority.
Another possibility is that a large proportion of patients with ventricular dysfunction are at low risk of events. Can neuroendocrine measurements supplement the information contained in the ejection fraction? Data 
